# InvaGen Pharmaceuticals, Inc. – FDA Inspection, May 1, 2023

Source: https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/05ff46c9-b916-4b26-a269-3ab2fec8e792
Source feed: FDA_Inspections

> FDA inspection 1205976 of InvaGen Pharmaceuticals, Inc., May 01, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205976
- Company Name: InvaGen Pharmaceuticals, Inc.
- Inspection Date: 2023-05-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)

Company: https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/ed84b9eb-799d-48d0-81cf-7656245b03a2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c